Worth reading
48Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
30000
Shares (number of shares underlying the stock acquisition rights)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as stock options
発行・処分する株式数
30,000 common shares (300 share acquisition rights, with 100 shares per right)
Intended allottee
Category Directors of the company's subsidiaries / Number of Employees 1 / Number of stock acquisition rights 200 rights, Category Employees of the company's subsidiaries / Number of Employees 1 / Number of stock acquisition rights 100
The share acquisition rights will be issued at no cost. The exercise price will be equal to the closing price of the Company’s common stock in regular trading on the Tokyo Stock Exchange on 14 April 2026, on a per-share basis.
Amount of funds to be raised
Amount paid in for the issuance of the share acquisition rights: ¥0. Amount paid in upon exercise and estimated net proceeds: Not disclosed
Terms of the stock acquisition rights
Exercise price
Equal to the closing price of the Company’s common stock in regular trading on the Tokyo Stock Exchange on 14 April 2026, on a per-share basis. The price may be adjusted in the event of a stock split or consolidation, gratis allotment or other event. Minimum price: Not disclosed
Exercise period
From 15 April 2028 to 14 April 2036
Number of Stock Acquisition Rights
Total number issued: 300. Number of unexercised rights outstanding: Not disclosed
Reason for acquisition without consideration
The occurrence of a corporate reorganization, transfer of more than half of the issued shares, share delivery, approval of a demand for the sale of shares or other securities, loss by a holder of the prescribed status, criminal sanctions, competition with the Company, misconduct, bankruptcy or other specified event, disciplinary grounds or breach of the duty of loyalty, dissolution of the Company or other event
Categories and Number of Persons Covered
Category Directors of the company's subsidiaries / Number of Employees 1 / Number allocated 200 rights, Category Employees of the company's subsidiaries / Number of Employees 1 / Number allocated 100
Payment date
No cash payment is required. Allotment date: 29 April 2026
Basis for determining the amount to be paid
The exercise price will be equal to the closing price of the Company’s common stock in regular trading on the Tokyo Stock Exchange on 14 April 2026. Discount rate and premium rate: Not disclosed
Procedures under the Corporate Code of Conduct
At a Board of Directors meeting held on 14 April 2026, the Company determined the offering terms and resolved to conduct the offering.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as stock options |
| Number of shares to be issued or disposed of | 30,000 common shares (300 share acquisition rights, with 100 shares per right) |
| Issue price and disposal price | The share acquisition rights will be issued at no cost. The exercise price will be equal to the closing price of the Company’s common stock in regular trading on the Tokyo Stock Exchange on 14 April 2026, on a per-share basis. |
| Amount of funds to be raised | Amount paid in for the issuance of the share acquisition rights: ¥0. Amount paid in upon exercise and estimated net proceeds: Not disclosed |
| Payment date | No cash payment is required. Allotment date: 29 April 2026 |
| Intended allottee | Category Directors of the company's subsidiaries / Number of Employees 1 / Number of stock acquisition rights 200 rights, Category Employees of the company's subsidiaries / Number of Employees 1 / Number of stock acquisition rights 100 |
| Basis for determining the amount to be paid | The exercise price will be equal to the closing price of the Company’s common stock in regular trading on the Tokyo Stock Exchange on 14 April 2026. Discount rate and premium rate: Not disclosed |
| Exercise price | Equal to the closing price of the Company’s common stock in regular trading on the Tokyo Stock Exchange on 14 April 2026, on a per-share basis. The price may be adjusted in the event of a stock split or consolidation, gratis allotment or other event. Minimum price: Not disclosed |
| Exercise period | From 15 April 2028 to 14 April 2036 |
| Number of Stock Acquisition Rights | Total number issued: 300. Number of unexercised rights outstanding: Not disclosed |
| Reason for acquisition without consideration | The occurrence of a corporate reorganization, transfer of more than half of the issued shares, share delivery, approval of a demand for the sale of shares or other securities, loss by a holder of the prescribed status, criminal sanctions, competition with the Company, misconduct, bankruptcy or other specified event, disciplinary grounds or breach of the duty of loyalty, dissolution of the Company or other event |
| Categories and Number of Persons Covered | Category Directors of the company's subsidiaries / Number of Employees 1 / Number allocated 200 rights, Category Employees of the company's subsidiaries / Number of Employees 1 / Number allocated 100 |
| Procedures under the Corporate Code of Conduct | At a Board of Directors meeting held on 14 April 2026, the Company determined the offering terms and resolved to conduct the offering. |
Items this document does not state (15)
Total issue valueEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To further heighten the awareness of directors and employees of the Company’s subsidiary regarding increases in the share price and improved medium- to long-term performance, thereby increasing shareholder value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.